TY - JOUR
T1 - Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs
AU - Mou, Hongmei
AU - Zhao, Rui
AU - Sherwood, Richard
AU - Ahfeldt, Tim
AU - Lapey, Allen
AU - Wain, John
AU - Sicilian, Leonard
AU - Izvolsky, Konstantin
AU - Musunuru, Kiran
AU - Cowan, Chad
AU - Rajagopal, Jayaraj
N1 - Funding Information:
The work in this manuscript was supported by a Harvard Stem Cell Institute Seed Grant and an NIH-NHLBI Early Career Research New Faculty (P30) award to J.R. We thank Drs. William Anderson and Darrell Kotton for reading this manuscript and for their critical comments. We also wish to extend our thanks to all of the members of the Rajagopal Laboratory for their reading of the text, their constructive criticisms and comments, and valuable discussion and support.
PY - 2012/4/6
Y1 - 2012/4/6
N2 - Deriving lung progenitors from patient-specific pluripotent cells is a key step in producing differentiated lung epithelium for disease modeling and transplantation. By mimicking the signaling events that occur during mouse lung development, we generated murine lung progenitors in a series of discrete steps. Definitive endoderm derived from mouse embryonic stem cells (ESCs) was converted into foregut endoderm, then into replicating Nkx2.1+ lung endoderm, and finally into multipotent embryonic lung progenitor and airway progenitor cells. We demonstrated that precisely-timed BMP, FGF, and WNT signaling are required for NKX2.1 induction. Mouse ESC-derived Nkx2.1+ progenitor cells formed respiratory epithelium (tracheospheres) when transplanted subcutaneously into mice. We then adapted this strategy to produce disease-specific lung progenitor cells from human Cystic Fibrosis induced pluripotent stem cells (iPSCs), creating a platform for dissecting human lung disease. These disease-specific human lung progenitors formed respiratory epithelium when subcutaneously engrafted into immunodeficient mice.
AB - Deriving lung progenitors from patient-specific pluripotent cells is a key step in producing differentiated lung epithelium for disease modeling and transplantation. By mimicking the signaling events that occur during mouse lung development, we generated murine lung progenitors in a series of discrete steps. Definitive endoderm derived from mouse embryonic stem cells (ESCs) was converted into foregut endoderm, then into replicating Nkx2.1+ lung endoderm, and finally into multipotent embryonic lung progenitor and airway progenitor cells. We demonstrated that precisely-timed BMP, FGF, and WNT signaling are required for NKX2.1 induction. Mouse ESC-derived Nkx2.1+ progenitor cells formed respiratory epithelium (tracheospheres) when transplanted subcutaneously into mice. We then adapted this strategy to produce disease-specific lung progenitor cells from human Cystic Fibrosis induced pluripotent stem cells (iPSCs), creating a platform for dissecting human lung disease. These disease-specific human lung progenitors formed respiratory epithelium when subcutaneously engrafted into immunodeficient mice.
UR - https://www.scopus.com/pages/publications/84859557287
U2 - 10.1016/j.stem.2012.01.018
DO - 10.1016/j.stem.2012.01.018
M3 - Article
C2 - 22482504
AN - SCOPUS:84859557287
SN - 1934-5909
VL - 10
SP - 385
EP - 397
JO - Cell Stem Cell
JF - Cell Stem Cell
IS - 4
ER -